全文获取类型
收费全文 | 46410篇 |
免费 | 2749篇 |
国内免费 | 114篇 |
专业分类
耳鼻咽喉 | 678篇 |
儿科学 | 2099篇 |
妇产科学 | 1062篇 |
基础医学 | 5688篇 |
口腔科学 | 1939篇 |
临床医学 | 4416篇 |
内科学 | 9495篇 |
皮肤病学 | 1142篇 |
神经病学 | 3863篇 |
特种医学 | 1416篇 |
外国民族医学 | 2篇 |
外科学 | 7137篇 |
综合类 | 169篇 |
一般理论 | 17篇 |
预防医学 | 3068篇 |
眼科学 | 1321篇 |
药学 | 3027篇 |
中国医学 | 184篇 |
肿瘤学 | 2550篇 |
出版年
2024年 | 44篇 |
2023年 | 354篇 |
2022年 | 327篇 |
2021年 | 838篇 |
2020年 | 568篇 |
2019年 | 890篇 |
2018年 | 1387篇 |
2017年 | 994篇 |
2016年 | 1109篇 |
2015年 | 1126篇 |
2014年 | 1401篇 |
2013年 | 2112篇 |
2012年 | 3271篇 |
2011年 | 3685篇 |
2010年 | 1918篇 |
2009年 | 1403篇 |
2008年 | 3127篇 |
2007年 | 3362篇 |
2006年 | 3252篇 |
2005年 | 3286篇 |
2004年 | 3168篇 |
2003年 | 2910篇 |
2002年 | 2795篇 |
2001年 | 917篇 |
2000年 | 1004篇 |
1999年 | 662篇 |
1998年 | 391篇 |
1997年 | 320篇 |
1996年 | 258篇 |
1995年 | 230篇 |
1994年 | 196篇 |
1993年 | 179篇 |
1992年 | 154篇 |
1991年 | 129篇 |
1990年 | 122篇 |
1989年 | 113篇 |
1988年 | 100篇 |
1987年 | 87篇 |
1986年 | 99篇 |
1985年 | 67篇 |
1984年 | 81篇 |
1983年 | 73篇 |
1982年 | 68篇 |
1981年 | 53篇 |
1980年 | 61篇 |
1979年 | 72篇 |
1978年 | 55篇 |
1977年 | 53篇 |
1974年 | 45篇 |
1973年 | 47篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
101.
Wassim Daher Lydie Pelinski Sylvie Klieber Freddy Sadoun Viviane Meunier Martine Bourrié Christophe Biot Fran?ois Guillou Gérard Fabre Jacques Brocard Laurent Fraisse Jean-Pierre Maffrand Jamal Khalife Daniel Dive 《Drug metabolism and disposition》2006,34(4):667-682
Ferroquine (SSR97193) has been shown to be a promising antimalarial, both on laboratory clones and on field isolates. So far, no resistance was documented in Plasmodium falciparum. In the present work, the metabolic pathway of ferroquine, based on experiments using animal and human hepatic models, is proposed. Ferroquine is metabolized mainly via an oxidative pathway into the major metabolite mono-N-demethyl ferroquine and then into di-N,N-demethyl ferroquine. Some other minor metabolic pathways were also identified. Cytochrome P450 isoforms 2C9, 2C19, and 3A4 and, possibly in some patients, isoform 2D6, are mainly involved in ferroquine oxidation. The metabolites were synthesized and tested against the 3D7 (chloroquine-sensitive) and W2 (chloroquine-resistant) P. falciparum strains. According to the results, the activity of the two main metabolites decreased compared with that of ferroquine; however, the activity of the mono-N-demethyl derivative is significantly higher than that of chloroquine on both strains, and the di-N-demethyl derivative remains more active than chloroquine on the chloroquine-resistant strain. These results further support the potential use of ferroquine against human malaria. 相似文献
102.
103.
Zvi Laron Jenny Frenkel lrit Gil-Ad Beatrice Klinger Ernesto Lubin Patrick Wuthrich François Boutignon Vincent Lengerts Romano Deghenghi 《Clinical endocrinology》1994,41(4):539-541
OBJECTIVE Hexarelin is a new synthetic growth hormone releasing peptide. We have tested the efficacy of intranasal (i.n.) administration of hexarelin to stimulate plasma GH and have compared this to the intravenous (i.v.) administration of the peptide. PATIENTS Ten children with familial short stature (FSS) aged 5·5-15·5 years and two known GH deficient patients aged 24 and 28 years without GH treatment. METHODS All 12 subjects were submitted to i.v. (1 μg/kg) and i.n. (20 μg/kg) hexarelin tests with a one-week interval between tests. Blood samples for GH, TSH, fT4 and T3 were obtained at 0, 15, 30, 60, 90 and 120 minutes. The hormone determinations were made by standard radio-immunoassays (RIA). RESULTS Both the i.n. and i.v. administration of hexarelin induced a large GH response, the mean (±SD) being 72·2± 35·5 mU/l for the i.n. test and 79·6 ± 53·0 mU/l for the i.v. test. The peak GH in the i.v. test occurred at 15–30 minutes and in the i.n. test between 30 and 60 minutes. The GH deficient patients showed no GH response In either test. Plasma TSH decreased in the FSS children from a mean (±SD) of 1.0 ± 0·26 to 0·64±0 2 mU/l (P<0 005) during the i.n. test and from 1·0±0·3 to 0·7±0·3mU/l (P> 0 05) during the I.v. test. In the isolated GH deficient patient, plasma TSH decreased from 1·06±0·38 mU/l to 0·86±0·17 during the i.v. test and from 1·60±0·01 to 1·11±0·06mU/l during the i.n. test. There were no significant changes in plasma fT4 or T3 in any of the tests. CONCLUSIONS The synthetic hexapeptide hexarelin is a potent pituitary GH stimulator when administered intra-nasally. The GH response was similar to that observed after intravenous hexarelin. Simultaneously, there was a significant decrease in plasma TSH but the concentrations remained in the normal range. These findings appear to be of theoretical and practical relevance to the investigation and management of short children. 相似文献
104.
Endothelin-1 in children with chronic renal failure 总被引:1,自引:0,他引:1
Isabelle Blazy Michèle Déchaux Marina Charbit Danièle Brocart Jean-Claude Souberbielle Marie France Gagnadoux François Guillot Charles Sachs 《Pediatric nephrology (Berlin, Germany)》1994,8(1):40-44
Endothelin-1 (ET-1) was meansured after extraction from plasma of normal adults (5.9±1.9 pg/ml,n=22), normal children (7.1±1.86 pg/ml,n=29), nonhaemodialysed children with chronic renal failure (CRF) (11.1±1.8 pg/ml),n=10), renal graft recipients (9.5±3.4 pg/ml,n=37), haemodialysed children 24 h after a haemodialysis session (20.02±10.9 pg/ml,n=26) and haemodialysed children before and after a haemodialysis session (15.31±10.6 and 13.8±8.5 respectively,n=14). A sensitive and specific radioimmunoassay was used. ET-1 was significantly higher in non-haemodialysed CRF children and in renal graft recipients than in normal children (P<0.001 andP<0.01, respectively) and significantly higher in haemodialysed children when compared with normal children, non-haemodialysed CRF children and renal graft recipients (P<0.001). ET-1 concentrations were similar in normal children and normal adults. ET-1 was inversely correlated with glomerular filtration rate in non-haemodialysed CRF children (r=–0.39,P<0.01) and positively correlated with extracellular volume in haemodialysed children (r=0.435,P<0.03). After haemodialysis, ET-1 increased in 6 and decreased in 8 of the 14 children studied before and after a haemodialysis session. 相似文献
105.
Matthieu Eveillard Patrice Mertl Blaise Tramier Fran?ois Eb 《Infection control and hospital epidemiology》2003,24(10):778-780
Effectiveness of gentamicin-impregnated cement in preventing deep wound infection after total knee arthroplasty (TKA) was estimated using data from prospective surveillance. In multivariate analysis, the protective effect of gentamicin-impregnated cement on the development of infection was close to the limit of significance. Gentamicin-impregnated cement may prevent TKA infections. 相似文献
106.
Jean-Fran?ois Ghersi-Egea Nathalie Strazielle Audrey Murat Anne Jouvet Annie Buénerd Marie-Fran?oise Belin 《Journal of cerebral blood flow and metabolism》2006,26(9):1165-1175
The choroid plexuses (CPs) form a protective interface between the blood and the ventricular cerebrospinal fluid (CSF). To probe into the pathways by which CPs provide brain protection, we sought to evaluate the efficiency of glutathione conjugation in this barrier as a mechanism to prevent the entry of blood-borne electrophilic, potentially toxic compounds into the CSF, and we investigated the fate of the resulting metabolites. Rat CPs, as well as human CPs from both fetal and adult brains, displayed high glutathione-S-transferase activities. Using an in vitro model of the blood-CSF barrier consisting of choroidal epithelial cells cultured in a two-chambered device, we showed that glutathione conjugation can efficiently prevent the entry of 1-chloro-2,4-dinitrobenzene (CDNB) into the CSF, a model for electrophilic compounds. The duration of this enzymatic protection was set by the concentration of CDNB to which the epithelium was exposed, and this barrier effect was impaired only on severe epithelial intracellular glutathione and cysteine depletion. The conjugate was excreted from the choroidal cells in a polarized manner, mostly at the blood-facing membrane, via a high-capacity transport process, which is not a rate-limiting step in this detoxification pathway, and which may involve transporters of the ATP-binding cassette c(Abcc) and/or solute carrier 21 (Slc21) families. Supplying the choroidal epithelium at the blood-facing membrane with a therapeutically relevant concentration of N-acetylcysteine sustained this neuroprotective effect. Thus, glutathione conjugation at the CP epithelium coupled with the basolateral efflux of the resulting metabolites form an efficient blood-CSF enzymatic barrier, which can be enhanced by pharmacologically increasing glutathione synthesis within the epithelial cells. 相似文献
107.
Luciana Dias de Oliveira Elsa Regina Justo Giugliani Lílian Córdova do Espírito Santo Maristela Cavalheiro Tamborindeguy Fran?a Enilda Maria Lara Weigert Celina Valderez Feijó Kohler Ana Lúcia de Lourenzi Bonilha 《Journal of human lactation》2006,22(3):315-321
This randomized clinical trial compared frequencies of exclusive breastfeeding and lactation-related problems during the first 30 days among 74 mothers who received a 30-minute counseling session on breastfeeding technique in the maternity ward, and 137 controls. The frequency of exclusive breastfeeding among mothers who had received intervention was similar to controls by 7 days (79.7% vs 82.5%, respectively) and 30 days (60.8% vs 53.3%). There was no difference between groups in the frequency of sore nipples at 7 and 30 days, in breast engorgement and mastitis, and in the quality of breastfeeding technique at 30 days. Therefore, a single intervention at maternity was not sufficient to improve breastfeeding technique, increase exclusive breastfeeding rates, and reduce the incidence of breastfeeding problems during the first month. 相似文献
108.
Nina Rieckmann William Gerin Ian M Kronish Matthew M Burg William F Chaplin Grace Kong Fran?ois Lespérance Karina W Davidson 《Journal of the American College of Cardiology》2006,48(11):2218-2222
OBJECTIVES: We tested whether improvements in depressive symptoms precede improved adherence to aspirin in patients with acute coronary syndromes (ACS). BACKGROUND: Depression is associated with medication nonadherence in patients with ACS, but it is unclear whether changes in depression impact on adherence. METHODS: Electronic medication monitoring was used to measure adherence to aspirin during a 3-month period in a consecutive cohort of 172 patients (25 to 85 years) recruited within 1 week of hospitalization for ACS. Depressive symptom severity was assessed using the Beck Depression Inventory (BDI) during hospitalization and at 1 and 3 months after hospitalization. Adherence was defined as the percentage of days aspirin was taken as prescribed. RESULTS: Depression severity in hospital was associated with nonadherence in a gradient fashion: 15% of non-depressed patients (BDI score 0 to 4), 29% of mildly depressed patients (BDI score 10 to 16), and 37% of patients with moderately-to-severely depressive symptoms (BDI score >16) took aspirin less than 80% of the time (p = 0.03). A cross-lagged path analytic model revealed that improvements in depressive symptoms in the first month after the ACS were associated with improvements in adherence rates in the subsequent 2 months (standardized direct effect -0.32, p = 0.016). CONCLUSIONS: Diagnosis and treatment of depressive symptoms may improve medication adherence in patients after ACS. 相似文献
109.
Sandrine Cappellesso Jean-Fran?ois Valentin Bruno Giraudeau Marie-Denise Boulanger Azmi Al-Najjar Mathias Büchler Jean-Michel Halimi Hubert Nivet Pierre Bardos Yvon Lebranchu Hervé Watier 《Nephrology, dialysis, transplantation》2004,19(2):439-443
BACKGROUND: Genetic factors other than HLA have been reported to be associated with the outcome of organ transplantations. Because binding of FasL to its receptor Fas could play an important role in tubulitis and in the death of graft tubular epithelial cells during kidney allograft rejection, a gene polymorphism recently identified in position -671 in the promoter of the TNFRSF6 gene coding for Fas was investigated in donors. METHODS: A case-control study was performed within a cohort of non-hyperimmunized adult patients who had received cadaveric kidney transplants based on the occurrence or absence of acute cellular rejection in the first 6 months after renal transplantation. Each recipient from the acute rejection group (n = 35) was matched for age (+/- 5 years) and number of HLA-DR mismatches with two recipients within the non-acute rejection group (n = 70). RESULTS: The TNFRSF6-GG genotype was more frequent in donors in the group without rejection episodes. In contrast, patients who received a kidney from a TNFRSF6-A carrier were more likely to experience acute rejection episodes (relative risk nearly 2.1). CONCLUSION: This study suggests that donor TNFRSF6 polymorphism directly or indirectly influences acute kidney rejection episodes. 相似文献
110.
Use of stereotactic PET images in dosimetry planning of radiosurgery for brain tumors: clinical experience and proposed classification. 总被引:13,自引:0,他引:13
Marc Levivier Nicolas Massager David Wikler José Lorenzoni Salvador Ruiz Daniel Devriendt Philippe David Fran?oise Desmedt Stéphane Simon Paul Van Houtte Jacques Brotchi Serge Goldman 《Journal of nuclear medicine》2004,45(7):1146-1154
We developed a technique that allows the routine integration of PET in stereotactic neurosurgery, including radiosurgery. We report our clinical experience with the combined use of metabolic (i.e., PET) and anatomic (i.e., MRI and CT) images for the radiosurgical treatment of brain tumors. We propose a classification describing the relative role of the information provided by PET in this multimodality image-guided approach. METHODS: Between December 1999 and March 2003, 57 patients had stereotactic PET as part of their image acquisition for the planning of gamma knife radiosurgery. Together with stereotactic MRI and CT, stereotactic PET images were acquired on the same day using either (18)F-FDG or (11)C-methionine. PET images were imported in the planning software for the radiosurgery dosimetry, and the target volume was defined using the combined information of PET and MRI or CT. To analyze the specific contribution of the PET findings, we propose a classification that reflects the strategy used to define the target volume. RESULTS: The patients were offered radiosurgery with PET guidance when their tumor was ill-defined and we anticipated some limitation of target definition on MRI alone. This represents 10% of the radiosurgery procedures performed in our center during the same period of time. There were 40 primary brain lesions, 7 metastases, and 10 pituitary adenomas. Abnormal PET uptake was found in 62 of 72 targets (86%), and this information altered significantly the MRI-defined tumor in 43 targets (69%). CONCLUSION: The integration of PET in radiosurgery provides additional information that opens new perspectives for the optimization of the treatment of brain tumors. 相似文献